Answers are grounded in this paper and cite their sources.
Preclinical findings demonstrate that elevated fatty acid impairs intestinal Tfh cell function in MASH, indicating a role in exacerbating fatty liver disease.
Description Metabolic dysfunction-associated steatohepatitis (MASH) is a severe form of fatty liver disease and a growing cause of liver cancer. The intestinal immune system plays a critical role in maintaining gut-liver homeostasis. T follicular helper (Tfh) cells in Peyer’s Patches (PPs) support germinal center (GC) responses that generate high-affinity intestinal IgA, which is essential for gut homeostasis. Indeed, Tfh-deficient mice showed disrupted intestinal permeability and heightened hepatic inflammation. Using a preclinical mouse model of MASH, we showed that a high-fat high-carbohydrate (HFHC) diet feeding induces an inflamed intestinal microenvironment, with enlarged PPs and expanded but dysfunctional ICOS+ CXCR5+ Tfh-like cells. These Tfh-like cells exhibited defective Tfh phenotype, and elevated KLF2, a transcription factor known to inhibit Tfh function, leading to impaired GC responses, and reduced IgA+ B cells. Conversely, reducing KLF2 expression in CD4 T cells improved Tfh function and alleviated MASH pathology, including hepatic steatosis, inflammation, and fibrosis. Mechanistically, the HFHC diet elevated palmitic acid levels in PPs, impairing TCR signaling in T cells, thus preventing proper KLF2 downregulation in Tfh. These findings underscore the crucial role of intestinal Tfh cells in regulating the gut-liver axis during MASH and identify elevated fatty acid as a key driver of their dysfunction, offering a potential therapeutic target for disease intervention.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: